Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
acquisition, advantage, amylase, Anderson, antitumor, approximately, area, ASCT, avidity, avoid, Center, CI, committed, coordinate, correlate, curve, dual, effector, EU, evidence, exploring, Fourteen, group, immunotherapy, induced, infiltration, injury, intratumoral, IST, lipase, maximum, MD, mechanism, median, Merkel, mid, mixed, MTD, Multidisciplinary, Nestl, Nestle, North, pancreatic, peak, peripheral, pre, presence, priming, proliferation, rash, recommended, reevaluate, repeated, Section, serum, SITC, small, sponsored, subsidiary, sufficient, survival, Symposium, timeline, transaminase, transplant, twelve, vacated, valency
Removed:
antidilutive, footnote, submission, VirBio
Filing tables
Filing exhibits
Related press release
Associated XNCR transcripts
XNCR similar filings
Filing view
External links